Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Neumora Therapeutics, Inc. | 6,046,907 | reported | 27 Oct 2025 | tx 12+20,840,404−17,424,704 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 Oct 2025 | PURCHASE | Neumora Therapeutics, Inc. | 1,915,700 | 2.61 USD | first after silence |
| 19 Sept 2023 | PURCHASE | Neumora Therapeutics, Inc. | 1,500,000 | 17.00 USD | |
| 19 Sept 2023 | CONVERSION | Neumora Therapeutics, Inc. | 2,124,143 | — | |
| 19 Sept 2023 | CONVERSION | Neumora Therapeutics, Inc. | 6,576,400 | — | |
| 19 Sept 2023 | CONVERSION | Neumora Therapeutics, Inc. | 6,895,021 | — | |
| 19 Sept 2023 | CONVERSION | Neumora Therapeutics, Inc. | 1,144,973 | — | |
| 19 Sept 2023 | CONVERSION | Neumora Therapeutics, Inc. | 684,167 | — | |
| 19 Sept 2023 | CONVERSION | Neumora Therapeutics, Inc. | 2,124,143 | — | deriv |
| 19 Sept 2023 | CONVERSION | Neumora Therapeutics, Inc. | 684,167 | — | deriv |
| 19 Sept 2023 | CONVERSION | Neumora Therapeutics, Inc. | 1,144,973 | — | deriv |
| 19 Sept 2023 | CONVERSION | Neumora Therapeutics, Inc. | 6,576,400 | — | deriv |
| 19 Sept 2023 | CONVERSION | Neumora Therapeutics, Inc. | 6,895,021 | — | deriv |
1 purchase reported after at least 12 months of silence — most recent on 27 Oct 2025.